adalimumab - adalimumab - aaty
(Adalimumab-Aaty)Celltrion Usa, Inc.
Celltrion Usa, Inc. drugs
10 results
avtozma
(tocilizumab)CELLTRION USA, Inc.Usage: AVTOZMA® (tocilizumab-anoh) is indicated for adults with moderately to severely active rheumatoid arthritis, giant cell arteritis, and hospitalized adults with COVID-19. It also treats active polyarticular and systemic juvenile idiopathic arthritis in patients aged 2 years and older.denosumab - bmwo - denosumab - bmwo injection
(Denosumab-Bmwo)Celltrion Usa, Inc.Usage: Denosumab-bmwo is indicated for preventing skeletal-related events in multiple myeloma and bone metastases, treating unresectable giant cell tumor of bone in adults and adolescents, and managing hypercalcemia of malignancy that is resistant to bisphosphonate therapy.denosumab - bmwo - denosumab - bmwo injection
(Denosumab-Bmwo)Celltrion Usa, Inc.Usage: Denosumab-bmwo is indicated for treating postmenopausal women and men with osteoporosis at high fracture risk, glucocorticoid-induced osteoporosis, and for increasing bone mass in men receiving androgen deprivation therapy for prostate cancer or women on aromatase inhibitor therapy for breast cancer.osenvelt - denosumab - bmwo injection
(Denosumab-Bmwo)Celltrion Usa, Inc.Usage: Osenvelt is indicated for preventing skeletal-related events in multiple myeloma and solid tumor bone metastases, treating unresectable giant cell tumor of bone in adults and skeletally mature adolescents, and managing hypercalcemia of malignancy that does not respond to bisphosphonate therapy.steqeyma - ustekinumab - stba injection, solution
(Ustekinumab-Stba)Celltrion Usa, Inc.stoboclo - denosumab - bmwo injection
(Denosumab-Bmwo)Celltrion Usa, Inc.Usage: Stoboclo is a RANKL inhibitor indicated for treating postmenopausal women and men with osteoporosis at high fracture risk, glucocorticoid-induced osteoporosis, and for increasing bone mass in men receiving androgen deprivation therapy for prostate cancer and women undergoing aromatase inhibitor therapy for breast cancer.tocilizumab-anoh
(tocilizumab)CELLTRION USA, Inc.Usage: Tocilizumab-anoh is indicated for treating moderately to severely active rheumatoid arthritis, giant cell arteritis, polyarticular and systemic juvenile idiopathic arthritis (ages 2+), and COVID-19 in hospitalized adults requiring respiratory support while on systemic corticosteroids.vegzelma - bevacizumab - adcd injection, solution
(Bevacizumab-Adcd)Celltrion Usa, Inc.yuflyma - adalimumab - aaty
(Adalimumab-Aaty)Celltrion Usa, Inc.